Physician profile
Robert M Pasciak
NPI 1760430037
$1,154.34
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.87 · 2020: $298 · 2021: $382 · 2022: $291 · 2023: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $361.07 | 2020-2023 | Xtandi |
| Neotract INC. | $292.23 | 2019-2020 | |
| Coloplast Corp | $140.49 | 2019-2023 | Speedicath |
| Bayer Healthcare Pharmaceuticals INC. | $91.12 | 2020-2021 | |
| Convatec INC. | $78.36 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $39.66 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $38.02 | 2021-2022 | |
| Boston Scientific Corporation | $30.37 | 2022 | |
| 180 Medical, INC. | $28.89 | 2022 | |
| Amgen INC. | $27.56 | 2022 | |
| Pfizer INC. | $14.63 | 2019 | |
| Blue Earth Diagnostics | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pasciak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.